Trial intelligence / Profile preview

Donepezil on Perceptual Learning in Adult Amblyopia

NCT03109314Phase 4Completed

Start
May 2012
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of donepezil in amblyopia (2 arms). Primary endpoints: Improvement in percent-correct performance in the respective training task, Visual acuity and 2 more. Started May 2012; status: completed.

02

Drugs

donepezil
03

Conditions

amblyopia

Beyond the preview

Go deeper on NCT03109314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03109314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call